Cancer Institute Drug Dictionary - description
Overview article on kinase inhibitors by Italian National Cancer Institute - published in Journal of Clinical Pharmacology
Chronic Myelogenous Leukemia treatment - National Cancer Institute
Valproic acid (VPA) is a HDAC inhibitor recently identified as a potential anticancer drug. Italian researchers found that a combination of VPA and bosutinib could kill colon cancer cells in the laboratory. They concluded the two drugs could be used together clinically in the future.
Overview from Department of Hematology and Oncology, University Hospital Aachen, Germany